Serum S100--a marker for disease monitoring in metastatic melanoma

Dermatology : International Journal for Clinical and Investigative Dermatology
G HenzeG Burg

Abstract

S100 proteins are low-molecular-weight calcium-binding proteins and appear to play an important role in various cellular processes such as cell division and differentiation. In histopathology, S100 is widely accepted as the marker of choice for immunohistochemical identification of malignant melanoma. When S100 was detected in the serum of patients with malignant melanoma, it was suggested that serum S100 may be a useful marker for the stage of disease. The aim of this study was to examine serum S100 concentrations of patients with different stages of malignant melanoma and to determine the value of serum S100 in the follow-up of melanoma patients during treatment. Sera were obtained from 73 melanoma patients in different stages of the disease. The control group consisted of 130 healthy subjects. In 4 patients with metastatic melanoma, serum S100 was measured serially. Serum levels were measured by a commercially available immunoradiometric assay. While only 1 out of 25 stage I/II patients and 3 of 14 patients with lymph node metastases (stage III, 21.4%) showed detectable serum S100 levels, 27 of 34 patients with disseminated disease (stage IV, 79.4%) had elevated serum S100. Interestingly, rising levels of serum S100 in the s...Continue Reading

Citations

Jun 27, 2000·Rapid Communications in Mass Spectrometry : RCM·L FerrariP Traldi
Jul 19, 2002·International Journal of Cancer. Journal International Du Cancer·Vera RebmannHans Grosse-Wilde
Mar 29, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Klaus StrobelHans C Steinert
May 7, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Klaus StrobelV Kalff
Jan 31, 2002·Journal of Chromatography. B, Biomedical Sciences and Applications·J Hartleb, R Arndt
Sep 25, 1998·The British Journal of Dermatology·M TronnierN Kock
Aug 22, 2000·The British Journal of Dermatology·L Brochez, J M Naeyaert
Mar 20, 2002·The British Journal of Dermatology·D DjukanovicD Schadendorf
Sep 22, 1999·Pathology Oncology Research : POR·T BánfalviS Ottó
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H GogasR Dummer
Oct 11, 2008·American Journal of Clinical Oncology·Raquel AndrésAlejandro Tres
Oct 27, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Josep Domingo-DomènechRafael Molina
Dec 16, 2010·European Journal of Medical Research·U H FreyN H Brockmeyer
Jul 29, 2009·Annals of Surgical Oncology·S KruijffH J Hoekstra
Dec 18, 2004·Dermatology : International Journal for Clinical and Investigative Dermatology·R DummerUNKNOWN Task Force Skin Cancer
Sep 8, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Klaus StrobelV Kalff
Jul 26, 2002·Melanoma Research·K StoitchkovT Le Bricon
Mar 14, 2008·Melanoma Research·Ragnar S FayeSteinar Aamdal
Oct 4, 2011·Mayo Clinic Proceedings·Shanique R PalmerSvetomir N Markovic
Nov 22, 2005·Dermatologic Therapy·Claus Garbe
Apr 21, 2004·Journal of the European Academy of Dermatology and Venereology : JEADV·M LomutoA Giuliani
Jul 25, 2009·The British Journal of Dermatology·L Jennings, G M Murphy
Mar 15, 2006·International Journal of Dermatology·Marjan YousefiRaymond L Barnhill
Apr 12, 2011·Journal of Surgical Oncology·Stanley P L LeongMohammed Kashani-Sabet
Dec 8, 2011·Journal of Neurochemistry·Fabrizio MichettiDiego Gazzolo
Feb 11, 2015·International Journal of Experimental Pathology·Corina DanciuCristina Dehelean
Dec 18, 2007·Seminars in Oncology·Spyros Retsas, Michael J Mastrangelo
Jul 6, 2004·Clinical Biochemistry·Riikka Harpio, Roland Einarsson
Sep 17, 1998·Journal of the American Academy of Dermatology·C L HuangR S Bart
Apr 29, 2005·Journal of the American Academy of Dermatology·J Andrew CarlsonMartin Mihm
Jun 1, 2014·BBA Clinical·Federica SalettaJennifer A Byrne
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claus GarbeGernot Rassner
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane VoitUlrich Keilholz
Aug 19, 2005·European Journal of Mass Spectrometry·Roberta SeragliaPietro Traldi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H B GuoD Klingmüller
© 2021 Meta ULC. All rights reserved